Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation

This publication has 27 references indexed in Scilit:

• Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody
  Oncogene, 2001
• Cancer statistics, 2000
  CA: A Cancer Journal for Clinicians, 2000
• Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation
  Cancer Biotherapy & Radiopharmaceuticals, 1999
• Pancreatic cancer
  Current Opinion in Oncology, 1998
• Epidermal Growth Factor Receptor Family and Chemosensitization
  JNCI Journal of the National Cancer Institute, 1997
• The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma
  Journal of Immunotherapy, 1996
• Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
  Journal of Clinical Investigation, 1995
• The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.
  Journal of Clinical Investigation, 1992
• The EGF Receptor System as a Target for Antitumor Therapy
  Cancer Investigation, 1991